Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose tPA in Massive Pulmonary Embolism (AYKAN Trial)
NCT02029456Phase 4Unknown
- Sponsor
- Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
- Start
- Jun 2011
- Primary completion
- Mar 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02029456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029456.